Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Restructuring Costs (2016)

Lipocine (LPCN) has disclosed Restructuring Costs for 3 consecutive years, with $343402.0 as the latest value for Q4 2016.

  • For the quarter ending Q4 2016, Restructuring Costs changed N/A year-over-year to $343402.0, compared with a TTM value of $343402.0 through Dec 2021, changed N/A, and an annual FY2021 reading of $4.0 million, changed N/A over the prior year.
  • Restructuring Costs was $343402.0 for Q4 2016 at Lipocine, down from $385233.0 in the prior quarter.
  • Across five years, Restructuring Costs topped out at $385233.0 in Q3 2016 and bottomed at $30.0 in Q2 2013.
  • Average Restructuring Costs over 3 years is $91155.2, with a median of $64.5 recorded in 2012.
  • Peak annual rise in Restructuring Costs hit 3.23% in 2013, while the deepest fall reached 87.1% in 2013.
  • Year by year, Restructuring Costs stood at $45.0 in 2012, then tumbled by 33.33% to $30.0 in 2013, then skyrocketed by 1144573.33% to $343402.0 in 2016.
  • Business Quant data shows Restructuring Costs for LPCN at $343402.0 in Q4 2016, $385233.0 in Q3 2016, and $30.0 in Q2 2013.